Been using this for over a year now, so I can give an honest review
A full list of references can be found on our website.
Because copper is a required cofactor for numerous enzymes involved in cellular metabolism and antioxidant activity, researchers studying GHK-Cus copper-binding properties often position it as a tool for understanding copper-dependent signaling pathways generally, not just those specific to skin or tissue repair
Their use in treating obesity has, however, been recognised in the past 5 to 10 years, in conjunction with experimental secondary uses for many of these drugs, such as treatment of dementia, Parkinsons, and autoimmune conditions
Yes, with a clear dose-response relationship: 0.25 mg dose: 9-11% constipation rate 0.5 mg dose: 12-14% constipation rate 1.0 mg dose: 15-18% constipation rate 2.4 mg dose: 23-24% constipation rate The increase from 0.5 mg to 2.4 mg roughly doubles the constipation risk